Skip to content
PubMed This is a summary of 58 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 58 referenced papers

Top Authors

Adeline Vanderver
Children's Hospital of Philadelphia
Marjo S. van der Knaap
Amsterdam Neuroscience
Jie Li
Renmin University of China
Laura Adang
Children's Hospital of Philadelphia
Guangping Gao
University of Massachusetts Chan Medical School
Yanhong Shi
City Of Hope National Medical Center
Joshua L. Bonkowsky
Primary Children's Hospital
Margaret Stroebe
University of Groningen
Susan E. Langmore
Boston University
Jorge N. Tendeiro
University of Groningen

Top Institutions

Ranked by publications Top 10 institutions
02

Mario Negri Institute for Pharmacological Research

Milan, Italy

1 paper
09

City Of Hope National Medical Center

Duarte, United States

15 papers

References

References (58)
  1. 1

    Leukodystrophy with multiple beaded periventricular cysts: unusual cranial MRI results in Canavan disease.

    Drenckhahn A, Schuelke M, Knierim E

    Journal of inherited metabolic disease 2015; (38(5)):983-4 doi:10.1007/s10545-015-9812-1.

    PMID: 25647544
  2. 2

    Canavan disease: an Arab scenario.

    Zayed H

    Gene 2015; (560(1)):9-14.

    PMID: 25668701
  3. 3

    Atypical clinical and radiological course of a patient with Canavan disease.

    Sarret C, Boespflug-Tanguy O, Rodriguez D

    Metabolic brain disease 2016; (31(2)):475-9 doi:10.1007/s11011-015-9767-9.

    PMID: 26586007
  4. 4

    Novel mutation in an Egyptian patient with infantile Canavan disease.

    Zaki OK, El Abd HS, Mohamed SA, Zayed H

    Metabolic brain disease 2016; (31(3)):573-7 doi:10.1007/s11011-015-9772-z.

    PMID: 26613958
  5. 5

    Structural modeling of p.V31F variant in the aspartoacylase gene.

    Krishnamoorthy N, Zayed H

    Metabolic brain disease 2016; (31(3)):723-6 doi:10.1007/s11011-016-9796-z.

    PMID: 26797702
  6. 6

    A case of Canavan disease with microcephaly.

    Gowda VK, Bhat MD, Srinivasan VM, et al.

    Brain & development 2016; (38(8)):759-62.

    PMID: 26992473
  7. 7

    rAAV Gene Therapy in a Canavan's Disease Mouse Model Reveals Immune Impairments and an Extended Pathology Beyond the Central Nervous System.

    Ahmed SS, Schattgen SA, Frakes AE, et al.

    Molecular therapy : the journal of the American Society of Gene Therapy 2016; (24(6)):1030-1041 doi:10.1038/mt.2016.68.

    PMID: 27039844
  8. 8

    Cytotoxic edema and diffusion restriction as an early pathoradiologic marker in canavan disease: case report and review of the literature.

    Merrill ST, Nelson GR, Longo N, Bonkowsky JL

    Orphanet journal of rare diseases 2016; (11(1)):169 doi:10.1186/s13023-016-0549-1.

    PMID: 27927234
  9. 9

    Clinically Distinct Phenotypes of Canavan Disease Correlate with Residual Aspartoacylase Enzyme Activity.

    Mendes MI, Smith DE, Pop A, et al.

    Human mutation 2017; (38(5)):524-531 doi:10.1002/humu.23181.

    PMID: 28101991
  10. 10

    Increasing N-acetylaspartate in the Brain during Postnatal Myelination Does Not Cause the CNS Pathologies of Canavan Disease.

    Appu AP, Moffett JR, Arun P, et al.

    Frontiers in molecular neuroscience 2017; (10()):161 doi:10.3389/fnmol.2017.00161.

    PMID: 28626388
  11. 11

    Pediatric leukodystrophies: The role of the otolaryngologist.

    Kay-Rivest E, Khendek L, Bernard G, Daniel SJ

    International journal of pediatric otorhinolaryngology 2017; (101()):141-144 doi:10.1016/j.ijporl.2017.07.039.

    PMID: 28964285
  12. 12

    Guilt in bereavement: Its relationship with complicated grief and depression.

    Li J, Tendeiro JN, Stroebe M

    International journal of psychology : Journal international de psychologie 2019; (54(4)):454-461 doi:10.1002/ijop.12483.

    PMID: 29508381
  13. 13

    Pathophysiology and Treatment of Canavan Disease.

    Pleasure D, Guo F, Chechneva O, et al.

    Neurochemical research 2020; (45(3)):561-565 doi:10.1007/s11064-018-2693-6.

    PMID: 30535831
  14. 14

    Development of bisubstrate analog inhibitors of aspartate N-acetyltransferase, a critical brain enzyme.

    Mutthamsetty V, Dahal GP, Wang Q, Viola RE

    Chemical biology & drug design 2020; (95(1)):48-57 doi:10.1111/cbdd.13586.

    PMID: 31260162
  15. 15

    A case of juvenile Canavan disease with distinct pons involvement.

    Çakar NE, Aksu Uzunhan T

    Brain & development 2020; (42(2)):222-225 doi:10.1016/j.braindev.2019.11.009.

    PMID: 31839386
  16. 16

    Antisense Oligonucleotide Reverses Leukodystrophy in Canavan Disease Mice.

    Hull V, Wang Y, Burns T, et al.

    Annals of neurology 2020; (87(3)):480-485 doi:10.1002/ana.25674.

    PMID: 31925837
  17. 17

    Racial/Ethnic and Insurance Status Disparities in Distance Traveled to Access Children's Hospital Care for Severe Illness: the Case of Children with Leukodystrophies.

    Grineski SE, Morales DX, Collins T, et al.

    Journal of racial and ethnic health disparities 2020; (7(5)):975-986 doi:10.1007/s40615-020-00722-w.

    PMID: 32095974
  18. 18

    Geographic and Specialty Access Disparities in US Pediatric Leukodystrophy Diagnosis.

    Grineski S, Morales DX, Collins T, et al.

    The Journal of pediatrics 2020; (220()):193-199 doi:10.1016/j.jpeds.2020.01.063.

    PMID: 32143930
  19. 19

    Epilepsy in children with leukodystrophies.

    Zhang J, Ban T, Zhou L, et al.

    Journal of neurology 2020; (267(9)):2612-2618 doi:10.1007/s00415-020-09889-y.

    PMID: 32388833
  20. 20

    Estimating the relative frequency of leukodystrophies and recommendations for carrier screening in the era of next-generation sequencing.

    Schmidt JL, Pizzino A, Nicholl J, et al.

    American journal of medical genetics. Part A 2020; (182(8)):1906-1912 doi:10.1002/ajmg.a.61641.

    PMID: 32573057
  21. 21

    Fiberoptic Endoscopic Evaluation of Swallowing Across the Age Spectrum.

    Miller CK, Schroeder JW, Langmore S

    American journal of speech-language pathology 2020; (29(2S)):967-978 doi:10.1044/2019_AJSLP-19-00072.

    PMID: 32650653
  22. 22

    Practical Approaches and Knowledge Gaps in the Care for Children With Leukodystrophies.

    Keller SR, Mallack EJ, Rubin JP, et al.

    Journal of child neurology 2021; (36(1)):65-78 doi:10.1177/0883073820946154.

    PMID: 32875938
  23. 23

    Severe retinal degeneration in a patient with Canavan disease.

    Benson MD, Plemel DJA, Freund PR, et al.

    Ophthalmic genetics 2021; (42(1)):75-78 doi:10.1080/13816810.2020.1827441.

    PMID: 32975148
  24. 24

    NGS-based expanded carrier screening for genetic disorders in North Indian population reveals unexpected results - a pilot study.

    Singh K, Bijarnia-Mahay S, Ramprasad VL, et al.

    BMC medical genetics 2020; (21(1)):216 doi:10.1186/s12881-020-01153-4.

    PMID: 33138774
  25. 25

    Cell-Based Therapy for Canavan Disease Using Human iPSC-Derived NPCs and OPCs.

    Feng L, Chao J, Tian E, et al.

    Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2020; (7(23)):2002155 doi:10.1002/advs.202002155.

    PMID: 33304759
  26. 26

    The mediating effect of social support and coping strategies on the relation between family stigma and caregiver burden among Israeli Arab family caregivers of people with Alzheimer's disease (AD).

    AboJabel H, Werner P

    Aging & mental health 2022; (26(8)):1597-1603 doi:10.1080/13607863.2021.1916881.

    PMID: 33904814
  27. 27

    The natural history of Canavan disease: 23 new cases and comparison with patients from literature.

    Bley A, Denecke J, Kohlschütter A, et al.

    Orphanet journal of rare diseases 2021; (16(1)):227 doi:10.1186/s13023-020-01659-3.

    PMID: 34011350
  28. 28

    Canavan Disease: Clinical and Laboratory Profile from Southern Part of India.

    Gowda VK, Bharathi NK, Bettaiah J, et al.

    Annals of Indian Academy of Neurology 2021; (24(3)):347-350 doi:10.4103/aian.AIAN_386_20.

    PMID: 34446995
  29. 29

    Ablating the Transporter Sodium-Dependent Dicarboxylate Transporter 3 Prevents Leukodystrophy in Canavan Disease Mice.

    Wang Y, Hull V, Sternbach S, et al.

    Annals of neurology 2021; (90(5)):845-850 doi:10.1002/ana.26211.

    PMID: 34498299
  30. 30

    Reliability of the Telemedicine Application of the Gross Motor Function Measure-88 in Patients With Leukodystrophy.

    Gavazzi F, Adang L, Waldman A, et al.

    Pediatric neurology 2021; (125()):34-39 doi:10.1016/j.pediatrneurol.2021.09.012.

    PMID: 34624609
  31. 31

    Alexander Disease.

    Hartog L, Dekeyzer S, Bossche SV

    Journal of the Belgian Society of Radiology 2021; (105(1)):61 doi:10.5334/jbsr.2588.

    PMID: 34723085
  32. 32

    Parents of Children With Newly Diagnosed Disorders of Sex Development Identify Major Concerns: A Qualitative Study.

    Boucher NA, Alkazemi MH, Tejwani R, Routh JC

    Urology 2022; (164()):218-223 doi:10.1016/j.urology.2022.01.001.

    PMID: 35038494
  33. 33

    Coping and guilt in informal caregivers: a predictive model based on structural equations.

    Muro Pérez-Aradros C, Navarro-Prados AB, Satorres E, et al.

    Psychology, health & medicine 2023; (28(4)):819-830 doi:10.1080/13548506.2022.2029917.

    PMID: 35057683
  34. 34

    Canavan's spongiform leukodystrophy (Aspartoacylase deficiency) with emphasis on sonographic features in infancy: description of a case report and review of the literature.

    Rossler L, Lemburg S, Weitkämper A, et al.

    Journal of ultrasound 2023; (26(4)):757-764 doi:10.1007/s40477-022-00667-2.

    PMID: 35187608
  35. 35

    Leukodystrophies.

    Adang L

    Continuum (Minneapolis, Minn.) 2022; (28(4)):1194-1216 doi:10.1212/CON.0000000000001130.

    PMID: 35938662
  36. 36

    Clustering of Juvenile Canavan disease in an Indian community due to population bottleneck and isolation: genomic signatures of a founder event.

    Kotambail A, Selvam P, Muthusamy K, et al.

    European journal of human genetics : EJHG 2023; (31(1)):73-80 doi:10.1038/s41431-022-01198-4.

    PMID: 36202930
  37. 37

    Cribriform Appearance of White Matter in Canavan Disease Associated with Novel Mutations of ASPA Gene.

    Bhat MD, Manjunath N, Kumari R, et al.

    Journal of pediatric genetics 2022; (11(4)):267-271 doi:10.1055/s-0041-1725118.

    PMID: 36267868
  38. 38

    An unusual case of a toddler with Canavan disease with frequent intractable seizures: A case report and review of the literature.

    Irilouzadian R, Goudarzi A, Hesami H, et al.

    SAGE open medical case reports 2023; (11()):2050313X231160885 doi:10.1177/2050313X231160885.

    PMID: 36968992
  39. 39

    Renewal of oligodendrocyte lineage reverses dysmyelination and CNS neurodegeneration through corrected N-acetylaspartate metabolism.

    Lotun A, Li D, Xu H, et al.

    Progress in neurobiology 2023; (226()):102460 doi:10.1016/j.pneurobio.2023.102460.

    PMID: 37149081
  40. 40

    Adeno-associated virus-mediated gene therapy in a patient with Canavan disease using dual routes of administration and immune modulation.

    Corti M, Byrne BJ, Gessler DJ, et al.

    Molecular therapy. Methods & clinical development 2023; (30()):303-314 doi:10.1016/j.omtm.2023.06.001.

    PMID: 37601414
  41. 41

    [Introduction of fiberoptic endoscopic evaluation of swallowing and increase of the range of indications in our department].

    Ambrus A, Rovó L, Sztanó B, et al.

    Orvosi hetilap 2023; (164(46)):1817-1823 doi:10.1556/650.2023.32912.

    PMID: 37980634
  42. 42

    Astroglial conditional Slc13a3 knockout is therapeutic in murine Canavan leukodystrophy.

    Hull VL, Wang Y, McDonough J, et al.

    Annals of clinical and translational neurology 2024; (11(4)):1059-1062 doi:10.1002/acn3.52010.

    PMID: 38282243
  43. 43

    Human induced pluripotent stem cell line (SDQLCHi064-A) derived from a patient with Canavan disease carrying c.556_559dup GTTC and c.919delA mutations in the ASPA gene.

    Liu N, Ge Y, Yang Y, et al.

    Stem cell research 2024; (76()):103325 doi:10.1016/j.scr.2024.103325.

    PMID: 38309148
  44. 44

    Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease.

    Grønbæk-Thygesen M, Hartmann-Petersen R

    Cell & bioscience 2024; (14(1)):45 doi:10.1186/s13578-024-01224-6.

    PMID: 38582917
  45. 45

    Homozygous Paternally Inherited ASPA Variant in a Patient with Canavan Disease.

    Yalcintepe S, Maras T, Kizilyar I, et al.

    Molecular syndromology 2024; (15(4)):284-288 doi:10.1159/000536386.

    PMID: 39119446
  46. 46

    Restoring Function in Pediatric Neurodegeneration: The Impact of Radio Electric Asymmetric Conveyor Neuroregenerative Treatment in a Child With Canavan Syndrome.

    Fontani V, Rinaldi A, Rinaldi S

    Cureus 2024; (16(11)):e73324 doi:10.7759/cureus.73324.

    PMID: 39524158
  47. 47

    Urine N-Acetylaspartate Distinguishes Phenotypes in Canavan Disease.

    Nagy A, Eichler F, Bley A, et al.

    Human gene therapy 2024; (36(1-2)):45-56 doi:10.1089/hum.2024.168.

    PMID: 39628365
  48. 48

    Feasibility, Acceptability, and Reliability of Remote Motor Assessment in Children With Canavan Disease.

    Kiefer M, Khan A, Leiro B, et al.

    Pediatric neurology 2025; (164()):129-136 doi:10.1016/j.pediatrneurol.2025.01.006.

    PMID: 39892021
  49. 49

    Experiences and needs of family caregivers for patients with End Stage Renal Disease (ESRD) in Palestine.

    Shaabna Z, S Abdalrahim M, Zeilani R

    BMC palliative care 2025; (24(1)):81 doi:10.1186/s12904-025-01722-5.

    PMID: 40128760
  50. 50

    Deep Intronic SVA_E Retrotransposition as a Novel Factor in Canavan Disease Pathogenesis.

    Weiß M, Selig M, Friedrich J, et al.

    Human gene therapy 2025; (36(17-18)):1248-1256 doi:10.1089/hum.2025.006.

    PMID: 40257001
  51. 51

    Implementation of a virtual dementia system of care in a VA health setting.

    Powers JS

    BMC geriatrics 2025; (25(1)):380 doi:10.1186/s12877-025-06034-0.

    PMID: 40437383
  52. 52

    A Mild Juvenile Onset Canavan Disease With Atypical Clinical Presentation and MRI Brain Features.

    Rehsi P, Siddiqui A, Singh R, et al.

    JIMD reports 2025; (66(4)):e70031 doi:10.1002/jmd2.70031.

    PMID: 40656657
  53. 53

    Gender differences in caregiver burden among informal caregivers of people with mental illness: A cross-sectional survey.

    Hu S, Yao H, Li K, et al.

    Archives of psychiatric nursing 2025; (57()):151929 doi:10.1016/j.apnu.2025.151929.

    PMID: 40816792
  54. 54

    Exploring the role of parental guilt in the association between parental self-efficacy and adjustment disorder among parents of children diagnosed with cancer.

    Kestler-Peleg M, Elbaz S, Kagan M

    Journal of psychiatric research 2025; (190()):327-332 doi:10.1016/j.jpsychires.2025.08.011.

    PMID: 40818222
  55. 55

    Oligodendrocyte-targeted adeno-associated virus gene therapy for Canavan disease in children: a phase 1/2 trial.

    Leone P, Lober RM, Francis J, et al.

    Nature medicine 2025; (31(11)):3772-3779 doi:10.1038/s41591-025-03919-w.

    PMID: 40957959
  56. 56

    Guilt in parents of children diagnosed with hemophilia: A qualitative study.

    Onel AE, Zengin D, Bal Yilmaz H

    Journal of pediatric nursing 2026; (86()):51-59 doi:10.1016/j.pedn.2025.10.032.

    PMID: 41207084
  57. 57

    The moderated mediation effect of caregiving stress and social support in the relationship between behavioral and psychological symptoms of dementia and caregiver burden in Oman: a cross-sectional study.

    Al Ghammari A, Guo M, Al Sinawi H, et al.

    BMC geriatrics 2025; (26(1)):21 doi:10.1186/s12877-025-06677-z.

    PMID: 41272598
  58. 58

    Understanding Parental Burnout in Parents of ADHD Children: Development and Psychometric Analysis of a New Questionnaire.

    Nejatifar S, Sharifi A, Sarami P

    Child psychiatry and human development 2025; doi:10.1007/s10578-025-01933-0.

    PMID: 41296259